Promising antimalarial drug proves ineffective at saving children’s lives

A large-scale study has found that rectal artesunate (RAS) has no beneficial effect on the survival of young children with severe malaria when used as an emergency treatment in resource-constrained settings. The study, which took place under real-world conditions in three African countries, concludes that the use of RAS is unlikely to reduce malaria deaths unless underlying health system weaknesses are addressed.

Leave a Comment

Your email address will not be published. Required fields are marked *